查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1951248

血型鑑定市場 - 全球產業規模、佔有率、趨勢、機會及預測（按產品、技術、檢測類型、最終用戶、地區和競爭格局分類，2021-2031年）

Blood Group Typing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Technique, By Test Type, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 186 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球血型鑑定市場預計將從 2025 年的 24.2 億美元成長到 2031 年的 40.5 億美元，複合年成長率達到 8.94%。

血型鑑定是一種診斷程序，用於識別紅血球上的特定ABO和Rh抗原，以確保輸血前的血清學相容性。該市場的主要成長要素是全球慢性血液疾病盛行率的上升以及需要即時輸血的創傷病例的增加。此外，越來越多的複雜外科手術需要嚴格的輸血前篩檢以確保病患安全，這持續推動醫療機構對精準血型鑑定試劑和自動化檢測系統的強勁需求。

市場概覽
預測期 2027-2031
市場規模：2025年 24.2億美元
市場規模：2031年 40.5億美元
複合年成長率：2026-2031年 8.94%
成長最快的細分市場 基於檢測的方法
最大的市場 北美洲

然而，由於血液供應不穩定，市場面臨許多重大障礙，阻礙了檢測流程的順利進行。捐血數量的下降給庫存管理帶來了巨大壓力，導致頻繁的供不應求，難以有效利用血型鑑定資源。例如，美國紅十字會報告稱，由於持續的捐血短缺，2024年7月全國血液庫存下降了超過25%。這種供應鏈的不穩定性造成了營運方面的挑戰，可能會阻礙血型鑑定市場的穩定成長。

市場促進因素

自動化和分子血型鑑定解決方案的技術創新正在從根本上重塑市場格局，顯著提升診斷準確性和營運效率。檢查室正日益從人工操作轉向全自動平台，最大限度地減少人為誤差，並實現ABO/Rh血型鑑定結果的標準化。這一轉變在關鍵診斷系統主要供應商的財務表現中得到了清晰的體現。例如，Grifols在2025年2月發布的「2024會計年度全年業績報告」中指出，其血型鑑定解決方案部門在主要國際市場實現了兩位數的成長。這一快速成長主要歸功於自動化設備的加速普及。這些技術不僅提高了處理速度，還提供了大型血站維持穩定工作流程所需的高通量處理能力。

同時，需要輸血的創傷病例的增加正成為市場擴張的主要驅動力。在急診室中，快速且準確的血型鑑定對於預防在救命手術過程中發生致命的輸血反應至關重要。血型鑑定試劑的需求與創傷中心收治的需要大量輸血的患者數量直接相關。正如美國紅十字會在其2025年5月發布的「創傷季捐血」新聞稿中所述，約25%的創傷患者需要輸血，這使得對相容性血液製品的需求變得迫切。這種持續的臨床需求支撐著耗材產業的穩定。例如，Quidel Orso在其2025年2月發布的「2024會計年度第四季及全年財務表現」中強調，其輸血醫學業務在2024年實現了超過90%的經常性收入成長，這證實了血型鑑定在現代醫學中不可或缺的重要性。

市場挑戰

血液供應的持續不穩定對血型鑑定市場構成重大限制，因為它直接限制了可進行的診斷檢測數量。隨著捐血人數的下降，血站和醫院立即面臨庫存短缺，迫使他們減少輸血前檢測的數量。這種直接關聯導致捐血數量減少，進而導致檢測試劑和自動化檢測平台的使用率降低。因此，檢查室無法維持穩定的偵測量，導致設備運轉率下降，以及必要的診斷耗材採購頻率降低。

這些供應鏈中斷造成了營運不穩定，阻礙了長期市場規劃和擴張。捐血參與度的不確定性迫使醫療機構保守地管理庫存，限制了血型鑑定產品的穩定消耗。例如，2024年7月，英國國家醫療服務體系（NHS）血液和移植服務中心報告稱，全國O型Rh陰性血的庫存已降至僅夠1.6天使用，迫使臨床人員將其使用限制在緊急情況下。如此嚴重的短缺降低了對血型鑑定服務的整體需求，阻礙了產業發展所需的持續產生收入，從而抑制了市場成長。

市場趨勢

人們對客製化檢測以識別罕見血型越來越感興趣，尤其關注那些需要精確表現型匹配的長期輸血患者的需求。在鐮狀細胞疾病等複雜病例中，標準的血清學檢測往往不足以預防同種免疫，因此需要廣泛的捐血篩檢計畫。這種臨床轉變使血站能夠更有效地管理多樣化的血庫，並確保難以匹配的受血者獲得匹配的血液。根據美國紅十字會2025年9月「鐮狀細胞疾病宣傳月」的新聞稿，該組織進行了超過30萬次鐮狀細胞攜帶者篩檢，這表明對這種精準檢測的需求日益成長，因為它是識別具有罕見抗原譜的匹配捐血者的關鍵措施。

同時，人類白血球抗原（HLA）分型應用範圍的不斷擴大，也使血型鑑定市場更加多元化。實驗室正拓展其診斷能力，不再侷限於傳統的紅血球抗原檢測，而是利用先進的基因組平台，為器官和幹細胞移植提供組織分型，實現高解析度匹配。將移植診斷整合到血庫工作流程中，標誌著血庫在支持複雜臨床干預方面，策略性地擴展了服務範圍。正如Wharfen在2025年3月發布的《2024年非財務資訊報告》中所述，該公司專業的移植部門佔據了12%的市場佔有率，這反映出業界對專業分型解決方案的日益重視。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球血型鑑定市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依產品（耗材、設備、服務）分類
    • 依技術分類（基於PCR和微陣列的技術、基於檢測的技術、大規模平行定定序等）
    • 依檢測類型（抗體篩檢、 HLA型檢測、ABO血型檢測、交叉配對試驗血、抗原分型）
    • 依最終使用者（醫院、臨床檢查室、血庫、其他最終使用者）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章 北美血型鑑定市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

7. 歐洲血型鑑定市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章 亞太地區血型鑑定市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章 中東和非洲血型鑑定市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章 南美洲血型鑑定市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球血型鑑定市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Illumina, Inc.
  • Immucor, Inc.
  • CareDx Inc.
  • Mesa Laboratories, Inc.
  • Bio-Rad Laboratories, Inc.
  • Merck KGaA
  • AliveDx Suisse SA
  • QuidelOrtho Corporation

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 23728

The Global Blood Group Typing Market is projected to expand from USD 2.42 Billion in 2025 to USD 4.05 Billion by 2031, achieving a CAGR of 8.94%. Blood group typing is a diagnostic procedure utilized to identify specific ABO and Rh antigens on red blood cells, ensuring serological compatibility before transfusion. The market is primarily driven by the increasing global prevalence of chronic hematologic disorders and a rising number of trauma cases that necessitate immediate blood replacement. Additionally, the growing volume of complex surgical procedures requires rigorous pre-transfusion screening to ensure patient safety, thereby sustaining strong demand for accurate typing reagents and automated assay systems across healthcare facilities.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 2.42 Billion
Market Size 2031USD 4.05 Billion
CAGR 2026-20318.94%
Fastest Growing SegmentAssay-Based Techniques
Largest MarketNorth America

However, the market encounters significant obstacles due to the volatility of blood supplies, which disrupts consistent testing workflows. A declining donor base places immense pressure on inventory management, frequently resulting in supply shortages that complicate the efficient use of typing resources. For example, the American Red Cross reported that the national blood inventory fell by more than 25 percent in July 2024 due to persistent donor shortages. This instability in the supply chain creates operational challenges that can impede the steady growth of the blood group typing market.

Market Driver

Technological innovations in automated and molecular blood typing solutions are fundamentally reshaping the market by improving diagnostic precision and operational efficiency. Laboratories are increasingly transitioning from manual methods to fully automated platforms, which minimize human error and standardize ABO/Rh typing results. This shift is financially evident in the performance of major industry players supplying these critical diagnostic systems. For instance, Grifols reported in their 'Full Year 2024 Results' in February 2025 that their Blood Typing Solutions division achieved double-digit growth in key international markets, a surge largely attributed to the accelerated adoption of these automated instruments. Such technologies not only enhance speed but also provide the high-volume processing capabilities necessary for maintaining steady workflows in large-scale blood centers.

Simultaneously, the rising incidence of trauma cases requiring transfusion acts as a primary catalyst for market expansion. Emergency medicine depends heavily on immediate and precise blood grouping to prevent fatal transfusion reactions during critical care interventions. The demand for typing reagents correlates directly with the volume of patients entering trauma centers who require substantial blood support. As noted by the American Red Cross in their May 2025 'Trauma Season Blood Donation' press release, approximately 25 percent of all trauma patients require blood transfusions, driving an urgent need for compatible blood products. This consistent clinical demand underpins the stability of the consumables sector; for example, QuidelOrtho highlighted in their February 2025 'Q4 and Full Year 2024 Financial Results' that the company's Transfusion Medicine business achieved over 90 percent recurring revenue in 2024, underscoring the essential nature of blood typing in modern healthcare.

Market Challenge

The persistent volatility of blood supplies functions as a substantial restraint on the blood group typing market by directly limiting the volume of diagnostic procedures performed. When donor participation declines, blood centers and hospitals face immediate inventory deficits, necessitating a reduction in the number of pre-transfusion tests conducted. This direct correlation means that a shrinking donor base results in lower utilization rates for typing reagents and automated assay platforms. Consequently, laboratories are unable to maintain consistent testing throughput, leading to idle equipment capacity and a reduced frequency of procurement for essential diagnostic consumables.

These supply chain disruptions introduce operational instability that hinders long-term market planning and expansion. The unpredictability of donor turnout forces healthcare facilities to manage inventories conservatively, restricting the steady consumption of typing products. For instance, NHS Blood and Transplant reported in July 2024 that national stocks of O Negative blood dropped to just 1.6 days, requiring clinical staff to restrict usage to emergency cases. Such critical shortages stall market growth by lowering the overall demand for typing services and preventing the continuous revenue generation necessary for industry development.

Market Trends

There is a growing focus on customized assays for rare blood group identification, prioritizing the needs of chronically transfused patients who require precise phenotypic matching. Standard serological tests are often insufficient for preventing alloimmunization in complex cases, such as those involving sickle cell disease, prompting the adoption of extensive donor screening programs. This clinical shift enables blood centers to manage diverse inventories more effectively and ensure compatibility for recipients who are difficult to match. According to the American Red Cross's September 2025 'Sickle Cell Awareness Month' press release, the organization supported this demand for precision by providing more than 300,000 sickle cell trait screenings, a critical measure for identifying compatible donors with rare antigen profiles.

Concurrently, the expansion of Human Leukocyte Antigen (HLA) typing applications is diversifying the operational scope of the blood group typing market. Laboratories are extending their diagnostic capabilities beyond traditional red cell antigens to include histocompatibility testing for organ and stem cell transplantation, utilizing advanced genomic platforms for high-resolution matching. This integration of transplant diagnostics into blood bank workflows represents a strategic broadening of services to support complex clinical interventions. As noted by Werfen in their March 2025 'Non-Financial Information Statement for 2024', the company's dedicated Transplant division secured a 12 percent share of the market, reflecting the increasing industrial emphasis on these specialized typing solutions.

Key Market Players

  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Illumina, Inc.
  • Immucor, Inc.
  • CareDx Inc.
  • Mesa Laboratories, Inc.
  • Bio-Rad Laboratories, Inc.
  • Merck KGaA
  • AliveDx Suisse SA
  • QuidelOrtho Corporation

Report Scope

In this report, the Global Blood Group Typing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Blood Group Typing Market, By Product

  • Consumables
  • Instruments
  • Services

Blood Group Typing Market, By Technique

  • PCR-Based and Microarray Techniques
  • Assay-Based Techniques
  • Massively Parallel Sequencing
  • Others

Blood Group Typing Market, By Test Type

  • Antibody Screening
  • HLA Typing
  • ABO Blood Tests
  • Cross-Matching Tests
  • Antigen Typing

Blood Group Typing Market, By End User

  • Hospitals
  • Clinical Laboratories
  • Blood Banks
  • Other End Users

Blood Group Typing Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Blood Group Typing Market.

Available Customizations:

Global Blood Group Typing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Blood Group Typing Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Consumables, Instruments, Services)
    • 5.2.2. By Technique (PCR-Based and Microarray Techniques, Assay-Based Techniques, Massively Parallel Sequencing, Others)
    • 5.2.3. By Test Type (Antibody Screening, HLA Typing, ABO Blood Tests, Cross-Matching Tests, Antigen Typing)
    • 5.2.4. By End User (Hospitals, Clinical Laboratories, Blood Banks, Other End Users)
    • 5.2.5. By Region
    • 5.2.6. By Company (2025)
  • 5.3. Market Map

6. North America Blood Group Typing Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Technique
    • 6.2.3. By Test Type
    • 6.2.4. By End User
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Blood Group Typing Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Technique
        • 6.3.1.2.3. By Test Type
        • 6.3.1.2.4. By End User
    • 6.3.2. Canada Blood Group Typing Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Technique
        • 6.3.2.2.3. By Test Type
        • 6.3.2.2.4. By End User
    • 6.3.3. Mexico Blood Group Typing Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Technique
        • 6.3.3.2.3. By Test Type
        • 6.3.3.2.4. By End User

7. Europe Blood Group Typing Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Technique
    • 7.2.3. By Test Type
    • 7.2.4. By End User
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Blood Group Typing Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Technique
        • 7.3.1.2.3. By Test Type
        • 7.3.1.2.4. By End User
    • 7.3.2. France Blood Group Typing Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Technique
        • 7.3.2.2.3. By Test Type
        • 7.3.2.2.4. By End User
    • 7.3.3. United Kingdom Blood Group Typing Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Technique
        • 7.3.3.2.3. By Test Type
        • 7.3.3.2.4. By End User
    • 7.3.4. Italy Blood Group Typing Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Technique
        • 7.3.4.2.3. By Test Type
        • 7.3.4.2.4. By End User
    • 7.3.5. Spain Blood Group Typing Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Technique
        • 7.3.5.2.3. By Test Type
        • 7.3.5.2.4. By End User

8. Asia Pacific Blood Group Typing Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Technique
    • 8.2.3. By Test Type
    • 8.2.4. By End User
    • 8.2.5. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Blood Group Typing Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Technique
        • 8.3.1.2.3. By Test Type
        • 8.3.1.2.4. By End User
    • 8.3.2. India Blood Group Typing Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Technique
        • 8.3.2.2.3. By Test Type
        • 8.3.2.2.4. By End User
    • 8.3.3. Japan Blood Group Typing Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Technique
        • 8.3.3.2.3. By Test Type
        • 8.3.3.2.4. By End User
    • 8.3.4. South Korea Blood Group Typing Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Technique
        • 8.3.4.2.3. By Test Type
        • 8.3.4.2.4. By End User
    • 8.3.5. Australia Blood Group Typing Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Technique
        • 8.3.5.2.3. By Test Type
        • 8.3.5.2.4. By End User

9. Middle East & Africa Blood Group Typing Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Technique
    • 9.2.3. By Test Type
    • 9.2.4. By End User
    • 9.2.5. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Blood Group Typing Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Technique
        • 9.3.1.2.3. By Test Type
        • 9.3.1.2.4. By End User
    • 9.3.2. UAE Blood Group Typing Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Technique
        • 9.3.2.2.3. By Test Type
        • 9.3.2.2.4. By End User
    • 9.3.3. South Africa Blood Group Typing Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Technique
        • 9.3.3.2.3. By Test Type
        • 9.3.3.2.4. By End User

10. South America Blood Group Typing Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Technique
    • 10.2.3. By Test Type
    • 10.2.4. By End User
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Blood Group Typing Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Technique
        • 10.3.1.2.3. By Test Type
        • 10.3.1.2.4. By End User
    • 10.3.2. Colombia Blood Group Typing Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Technique
        • 10.3.2.2.3. By Test Type
        • 10.3.2.2.4. By End User
    • 10.3.3. Argentina Blood Group Typing Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Technique
        • 10.3.3.2.3. By Test Type
        • 10.3.3.2.4. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Blood Group Typing Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Thermo Fisher Scientific Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Danaher Corporation
  • 15.3. Illumina, Inc.
  • 15.4. Immucor, Inc.
  • 15.5. CareDx Inc.
  • 15.6. Mesa Laboratories, Inc.
  • 15.7. Bio-Rad Laboratories, Inc.
  • 15.8. Merck KGaA
  • 15.9. AliveDx Suisse SA
  • 15.10. QuidelOrtho Corporation

16. Strategic Recommendations

17. About Us & Disclaimer